Prevalence of cervical cytological abnormalities in Turkey

dc.authoridKaraca, Mehmet/0000-0003-3219-9109
dc.authoridKösem, Mustafa/0000-0002-2347-0940
dc.authoridmutlu, ahmet emin/0000-0002-5092-1364
dc.authoridGultekin, Murat/0000-0002-4221-4459
dc.authoridGuven, Suleyman/0000-0003-4832-4525
dc.authoridKiran, Gurkan/0000-0002-6300-328X
dc.authoridKocak, Cengiz/0000-0003-3819-6822
dc.authorwosidbatur, sebnem/C-5097-2017
dc.authorwosidersöz, safak/AAM-9041-2021
dc.authorwosidKaraca, Mehmet/C-2683-2009
dc.authorwosidKösem, Mustafa/JCE-7269-2023
dc.authorwosidKocak, Cengiz/O-6011-2018
dc.authorwosidmutlu, ahmet emin/CAH-0350-2022
dc.authorwosidGultekin, Murat/AAQ-5865-2020
dc.contributor.authorKara, Fadil
dc.contributor.authorKiran, Guerkan
dc.contributor.authorMetindir, Jale
dc.contributor.authorOzan, Hakan
dc.contributor.authorOzalp, Sinan
dc.contributor.authorVardar, M. Ali
dc.contributor.authorZeren, Handan
dc.date.accessioned2024-08-04T20:31:17Z
dc.date.available2024-08-04T20:31:17Z
dc.date.issued2009
dc.departmentİnönü Üniversitesien_US
dc.description.abstractObjective: To evaluate retrospectively the prevalence of cervical cytological abnormalities in patient records obtained from healthcare centers in Turkey. Method: Demographic characteristics and data on cervical cytological abnormalities were evaluated from patients who underwent flap tests in healthcare centers in 2007. Results: Data were collected from 33 healthcare centers totaling 140 334 patients. Overall, the prevalence of cervical cytological abnormalities was 1.8%; the prevalence of ASCUS, ASC-H, LSIL, HSIL, and AGC was 1.07%, 0.07%, 0.3%, 0.17%, and 0.08%, respectively. The prevalence of preinvasive cervical neoplasia was 1.7% and the prevalence of cytologically diagnosed invasive neoplasia was 0.06%. Conclusion: The abnormal cervical cytological prevalence rate in Turkey is lower than in Europe and North America. This might be due to sociocultural differences, lack of population-based screening programs, or a lower HPV prevalence rate in Turkey. (C) 2009 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.en_US
dc.identifier.doi10.1016/j.ijgo.2009.04.003
dc.identifier.endpage209en_US
dc.identifier.issn0020-7292
dc.identifier.issn1879-3479
dc.identifier.issue3en_US
dc.identifier.pmid19541303en_US
dc.identifier.scopus2-s2.0-68349139717en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage206en_US
dc.identifier.urihttps://doi.org/10.1016/j.ijgo.2009.04.003
dc.identifier.urihttps://hdl.handle.net/11616/94850
dc.identifier.volume106en_US
dc.identifier.wosWOS:000269782800005en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofInternational Journal of Gynecology & Obstetricsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCervical canceren_US
dc.subjectCervical cytologyen_US
dc.subjectCervical intraepithelial neoplasiasen_US
dc.subjectCervical neoplasiasen_US
dc.subjectPap testen_US
dc.subjectPap smearen_US
dc.subjectTurkeyen_US
dc.titlePrevalence of cervical cytological abnormalities in Turkeyen_US
dc.typeArticleen_US

Dosyalar